Figure 8.

(A) The tumor volume variation of SGC7901/ADR tumor-bearing BALB/c mice after intravenous injection administration of different formulations. The treatment was implemented by intravenous injection every 2 days for 7 times at a QC/DOX dosage of 5 mg/kg. Data are expressed as mean ± SD (n=6). (B) Variation of protein expression in different formulation-treated tumor tissues as compared to control. Data are shown as mean ± SD (n=3). **P<0.01 vs HA-SiLN/D. (C) Hematoxylin and eosin staining images (400×) of tumor tissues from different formulation-treated groups.

Abbreviations: d, days; DOX, doxorubicin; QC, quercetin.